China’s early-stage cancer screening biotech company New Horizon Health announced today that it has raised US$20 million in a Series D financing round, led by private equity fund Omniscience. American Exome Asset Management, and existing investors Qiming Venture Partners, SBCVC also participated in the round, which will be used for the development of new product […]
Chinese Cancer Screening Firm New Horizon Health Raises $20M In Series D Round comes from China Money Network: Primary Data for China's Primary Markets! All Rights Reserved.